Poll: Identify the Main Cause for Reverse Switching


Reverse switching occurs when patients transitioned to or initiated on a biosimilar are changed to an originator product, often because of a perceived failure in the biosimilar therapy.

Which do you think is the main reason for reverse switching?

Lack of confidence in biosimilars among health care practitioners
Nocebo/failure to properly educate patients about biosimilars
Differences between biosimilars and originator agents
Lack of clear policy on managing patients with negative outcomes
Related Videos
Fran Gregory, PharmD, MBA
Julie Reed
Related Content
© 2023 MJH Life Sciences

All rights reserved.